S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- George H. Yoo, MD
Barbara Ann Karmanos Cancer Institute
Study Chair - Harold E. Kim, MD
Barbara Ann Karmanos Cancer Institute
Study Chair - Prakash C. Neupane, MD
St. Mary's Cancer Specialists at St. Mary's Health Center
Principal Investigator - Stephen K. Williamson, MD
University of Kansas
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Usc/norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
- Decatur Memorial Hospital Cancer Care Institute
Decatur, Illinois, United States
- Regional Cancer Center at Memorial Medical Center
Springfield, Illinois, United States
- Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas, United States
- Feist-Weiller Cancer Center at Louisiana State University Health Sciences
Shreveport, Louisiana, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- Saint Louis University Cancer Center
St Louis, Missouri, United States
- Rutherford Hospital
Rutherfordton, North Carolina, United States
- Adena Regional Medical Center
Chillicothe, Ohio, United States
- Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
- Ccop - Columbus
Columbus, Ohio, United States
- Doctors Hospital at Ohio Health
Columbus, Ohio, United States
- Grant Riverside Cancer Services
Columbus, Ohio, United States
- Mount Carmel Health - West Hospital
Columbus, Ohio, United States
- Riverside Methodist Hospital Cancer Care
Columbus, Ohio, United States
- Grady Memorial Hospital
Delaware, Ohio, United States
- Community Oncology Group at Cleveland Clinic Cancer Center
Independence, Ohio, United States
- Fairfield Medical Center
Lancaster, Ohio, United States
- Strecker Cancer Center at Marietta Memorial Hospital
Marietta, Ohio, United States
- Licking Memorial Cancer Care Program at Licking Memorial Hospital
Newark, Ohio, United States
- Community Hospital of Springfield and Clark County
Springfield, Ohio, United States
- Mercy Medical Center
Springfield, Ohio, United States
- Mount Carmel Cancer Services at Mount Carmel St. Ann'S Hospital
Westerville, Ohio, United States
- Cleveland Clinic - Wooster
Wooster, Ohio, United States
- Genesis - Good Samaritan Hospital
Zanesville, Ohio, United States
- Anmed Health Cancer Center
Anderson, South Carolina, United States
- Ccop - Upstate Carolina
Spartanburg, South Carolina, United States
- Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
Spartanburg, South Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2005
- Primary completion
- 31 Jan 2007
- Completion
- 31 Jan 2007
- Last update posted
- 14 Jun 2012
- Registered enrollment
- 0
- Registry id
- NCT00084435
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.